 'high single-dos european puva regimen excess non-melanoma skin cancer result long-term year studi detect malign benign skin tumour patient psoriasi puva european single-dos regimen total squamou cell carcinoma scc basal cell carcinoma bcc patient incid scc bcc comparison gener dutch popul ratio scc bcc gener popul studi group posit correl develop scc total uva dosag age patient start puva treatment histori arsen use dose-rel increas incid scc studi european studi averag time period start puva therapi diagnosi first malign tumour year scc year bcc benign skin tumour actin keratos keratoacanthoma 'puva keratos hyperkeratot lesion puva-tr patient